18Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans

Positron emission tomographic (PET) data on local cerebral metabolic rates for glucose (LCMR) are reported for 32 regions of interest (ROI)s in cross-sectional studies on 57 patients with clinically diagnosed Alzheimer's disease (AD) and 20 neurologically normal controls, and in serial studies on 13 of the AD cases, including a familial, young-onset case where the diagnosis has been confirmed at autopsy. Extensive psychological testing was done on all the AD cases. Almost all cortical regions showed a significant decline in LCMR with age in the control subjects. There were the expected cortical metabolic deficits in AD and the serial studies showed a general increase in such deficits over time in 12 of the 13 cases. The regions showing the greatest declines with time in serial studies are the same as those showing the most severe deficiencies in cross-sectional studies. The young-onset case did not show a greater rate of metabolic decline than many of the older cases studied. Results on individual psychological tests tended to correlate with metabolic rates in multiple, rather than single, cortical regions, suggesting intact neuronal networks are required for good performance. The correlations with cortical metabolic activity found were of a sign indicating that the higher the metabolic rates and the better the left:right asymmetry index, the better was the performance.

[1]  G. Rodriguez,et al.  Sex Differences in Regional Cerebral Blood Flow , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  B. L. Beattie,et al.  Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  W. Jagust,et al.  Longitudinal studies of regional cerebral metabolism in Alzheimer's disease , 1988, Neurology.

[4]  M D Ginsberg,et al.  Sensitivity of Cerebral Glucose Metabolism to Age, Gender, Brain Volume, Brain Atrophy, and Cerebrovascular Risk Factors , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  B Horwitz,et al.  Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. , 1988, Journal of clinical and experimental neuropsychology.

[6]  H. Tuokko,et al.  Cued recall and memory disorders in dementia. , 1989, Journal of clinical and experimental neuropsychology.

[7]  R Harrop,et al.  Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease , 1986, Neurology.

[8]  P. Mcgeer,et al.  Systems model of cortical organization: positron emission tomography and neuropsychological test performance. , 1989, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[9]  L. Viney,et al.  Promoting Independence in the Elderly , 1989 .

[10]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[11]  J D Brodie,et al.  Reproducibility of Cerebral Glucose Metabolic Measurements in Resting Human Subjects , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[13]  P. Mcgeer,et al.  Crossed cerebellar and uncrossed basal ganglia and thalarnic diaschisis in Alzheimer's disease , 1989, Neurology.

[14]  Arne Brun,et al.  PATHOLOGICAL AND POSITRON EMISSION TOMOGRAPHIC CORRELATIONS IN ALZHEIMER'S DISEASE , 1985, The Lancet.

[15]  M. Rossor,et al.  Familial Alzheimer's disease. , 1992, Bailliere's clinical neurology.

[16]  W. Heiss,et al.  Zerebraler Glukosestoffwechsel bei präseniler Demenz vom Alzheimer-Typ - Verlaufskontrolle unter Therapie mit muskarinergem Cholinagonisten - , 1986 .

[17]  P. Mcgeer,et al.  Brain imaging in Alzheimer's disease. , 1986, British medical bulletin.

[18]  H. Tuokko,et al.  The Assessment of Everyday Functioning Using the Present Functioning Questionnaire and the Functional Rating Scale in Elderly Samples , 1989 .

[19]  D. Crockett,et al.  A Multi-focus Assessment Scale for Use With Frail Elderly Populations , 1985, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[20]  D. Kingsley Atlas of the Human Brain and the Orbit for Computed Tomography , 1981 .

[21]  C. L. Grady,et al.  Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type , 1986, Neurology.

[22]  J. Haxby,et al.  Positron emission tomography in Alzheimer's disease , 1986, Neurology.

[23]  J. Haxby,et al.  Brain metabolism as measured with positron emission tomography , 1985, Neurology.

[24]  Jonathan D. Brodie,et al.  Positron emission tomography studies of normal aging: A replication of PET III and 18-FDG using PET VI and 11-CDG , 1987, Neurobiology of Aging.

[25]  R J Zatorre,et al.  Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  Robert P. Friedland,et al.  Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization , 1985, Neuroscience Letters.

[27]  James V. Haxby,et al.  Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.